Resources

Koneksa Blog

Blog Posts

Koneksa is at the forefront of digital biomarker discovery and testing, and our science-based understanding of their capabilities across therapeutic areas gives us a unique perspective. We are proud to share our insights, and we welcome your inquiries. Explore our articles to gain insights into the potential of digital biomarkers in clinical research.

Found 95 Results
Page 3 of 16
Article

End of Year Message from Koneksa

Dear Friends, As the year comes to a close, we are grateful for the progress we have made toward our vision of developing digital measures that benefit patients and are... Download
News

Koneksa Publishes Syndication Model to Accelerate Drug Discovery Using Digital Health Data in Clinical and Translational Science

New York, NY – December 10, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled: “Syndication in Science:... Download
News

Koneksa Appoints Eric Luthi as Chief Business Officer

NEW YORK–(BUSINESS WIRE)– Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the appointment of Eric Luthi as Chief Business Officer. In this newly created role, Mr. Luthibrings... Download
Article

Koneksa PD Day and MJFF

In the same week that the Michael J. Fox Foundation (MJFF) held its 14th annual Parkinson’s Disease (PD) Therapeutics Conference in New York City, Koneksa held its inaugural PD Day.... Download
Article

Digital Health Takes Center Stage at the MDS Conference

This year’s International Parkinson and Movement Disorder Society (MDS) was held over the last weekend of September in Philadelphia. The theme, “Movement Disorders in the Digital Age: Harnessing AI for... Download
News

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study

NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that Regeneron has become a member of its Data Syndication Program for the LEARNS observational study. This... Download